Healthcare provider profile · identity verified

Punit Bhutwala, MD

Internal Medicine · CHATTANOOGA, TN · NPI 1316919384

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	451	51
Furosemide	Furosemide	333	39
Eliquis	Apixaban	271	38
Potassium Chloride	Potassium Chloride	255	56
Atorvastatin Calcium	Atorvastatin Calcium	224	57
Pantoprazole Sodium	Pantoprazole Sodium	197	46
Gabapentin	Gabapentin	195	34
Amlodipine Besylate	Amlodipine Besylate	171	38
Trazodone Hcl	Trazodone Hcl	166	24
Carvedilol	Carvedilol	156	27
Metoprolol Tartrate	Metoprolol Tartrate	148	31
Sertraline Hcl	Sertraline Hcl	130	27
Tamsulosin Hcl	Tamsulosin Hcl	124	27
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	106	38
Xarelto	Rivaroxaban	106	11
Oxycodone Hcl	Oxycodone Hcl	99	suppressed
Citalopram Hbr	Citalopram Hydrobromide	96	14
Losartan Potassium	Losartan Potassium	95	24
Quetiapine Fumarate	Quetiapine Fumarate	92	16
Torsemide	Torsemide	92	13
Jardiance	Empagliflozin	86	12
Lisinopril	Lisinopril	83	19
Escitalopram Oxalate	Escitalopram Oxalate	79	13
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	75	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	13
Clopidogrel	Clopidogrel Bisulfate	73	18
Pravastatin Sodium	Pravastatin Sodium	71	11
Hydralazine Hcl	Hydralazine Hcl	68	14
Spironolactone	Spironolactone	66	16
Clonidine Hcl	Clonidine Hcl	62	suppressed
Sodium Chloride	0.9 % Sodium Chloride	62	40
Mirtazapine	Mirtazapine	60	19
Duloxetine Hcl	Duloxetine Hcl	58	15
Lantus	Insulin Glargine,hum.Rec.Anlog	58	16
Levetiracetam	Levetiracetam	58	11
Ceftriaxone	Ceftriaxone Sodium	57	26
Isosorbide Mononitrate Er	Isosorbide Mononitrate	57	14
Allopurinol	Allopurinol	54	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	48	19
Buspirone Hcl	Buspirone Hcl	47	suppressed
Divalproex Sodium	Divalproex Sodium	47	suppressed
Finasteride	Finasteride	47	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	46	suppressed
Levofloxacin	Levofloxacin	45	25
Ondansetron Hcl	Ondansetron Hcl	45	22
Lactulose	Lactulose	44	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	42	suppressed
Januvia	Sitagliptin Phosphate	42	suppressed
Alprazolam	Alprazolam	40	11
Humalog	Insulin Lispro	40	21
Novolog	Insulin Aspart	39	16
Baclofen	Baclofen	38	suppressed
Metoprolol Succinate	Metoprolol Succinate	38	11
Olanzapine	Olanzapine	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	37	24
Simvastatin	Simvastatin	37	suppressed
Farxiga	Dapagliflozin Propanediol	36	suppressed
Tramadol Hcl	Tramadol Hcl	36	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Famotidine	Famotidine	34	22
Omeprazole	Omeprazole	34	14
Donepezil Hcl	Donepezil Hcl	33	suppressed
Metformin Hcl	Metformin Hcl	32	12
Ibuprofen	Ibuprofen	31	suppressed
Lidocaine Hcl	Lidocaine Hcl	31	22
Carbidopa-Levodopa	Carbidopa/Levodopa	30	suppressed
Latanoprost	Latanoprost	28	11
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Bumetanide	Bumetanide	27	suppressed
Fluconazole	Fluconazole	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	16
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Movantik	Naloxegol Oxalate	25	suppressed
Albuterol Sulfate	Albuterol Sulfate	24	suppressed
Cephalexin	Cephalexin	24	12
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	13
Doxycycline Hyclate	Doxycycline Hyclate	23	11
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Diltiazem Hcl	Diltiazem Hcl	22	suppressed
Prazosin Hcl	Prazosin Hcl	22	suppressed
Amantadine	Amantadine Hcl	21	suppressed
Digoxin	Digoxin	21	suppressed
Dilt-Xr	Diltiazem Hcl	21	suppressed
Doxepin Hcl	Doxepin Hcl	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	19	16
Lorazepam	Lorazepam	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Estradiol	Estradiol	18	suppressed
Admelog	Insulin Lispro	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Diazepam	Diazepam	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Ranolazine Er	Ranolazine	17	suppressed
Risperidone	Risperidone	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Valsartan	Valsartan	17	suppressed
Ertapenem	Ertapenem Sodium	16	suppressed
Sucralfate	Sucralfate	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Temazepam	Temazepam	13	suppressed
Atenolol	Atenolol	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Insulin Aspart	Insulin Aspart	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Trimethoprim	Trimethoprim	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Perphenazine	Perphenazine	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error